Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

Just had a chance to listen to the presentation you cited, and it is informative. The pt may have been better off with Kevetrin- we just don't know.

Today in the ED I saw a pt with metastatic ovarian CA, and had a chance to ask the oncologist at my hospital who agrees that the CA 125 inreasing usu means increased tumor burden.

He did not have to look it up on Wikipedia.

BUT is 10% a real increase? And he also said the numbers can bump around a bit.
All of us wish we knew more about the 3 dozen or so pts, and how they have done, but especially important are the current doses if this is where Menon etc hope to see real impact

Would he push for NASDAQ if data are not good? Or does he believe it does not matter, and Brilacidin is enough to move forward with(plus waiting in the wings stuff)?

Thank you for mentioning the tape. One hopes that K might make a difference in the lives of many cancer patients.